BHLHE40 and cancer: Among these differential RNAs from TGF-β1-EVs treated HPASMCs, palladin and bHLHE40 (also called Dec1), which have been shown to promote a malignant pro-proliferative phenotype in cancer cells by promoting epithelial-to-mesenchymal transition [36–39], were further validated.